Matthew Man Pok Lee, Landon Long Chan, & Stephen Lam Chan. (2023). The role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma. Korean Liver Cancer Association.
Chicago Style (17th ed.) CitationMatthew Man Pok Lee, Landon Long Chan, and Stephen Lam Chan. The Role of Lenvatinib in the Era of Immunotherapy of Hepatocellular Carcinoma. Korean Liver Cancer Association, 2023.
MLA (9th ed.) CitationMatthew Man Pok Lee, et al. The Role of Lenvatinib in the Era of Immunotherapy of Hepatocellular Carcinoma. Korean Liver Cancer Association, 2023.
Warning: These citations may not always be 100% accurate.